Skip to main content

InflaRx N.V.

IFRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001708688

No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding InflaRx N.V. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of IFRX: Q2 2024 compared with Q3 2024
MeasureQ2 2024Q3 2024Change
Holders3327−6
Shares13.2M12.9M−336.9K (−2.6%)
Value$23.0M$19.7M−$3.28M (−14.3%)

New holders (4)

Institutions that held InflaRx N.V. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to IFRX in Q3 2024
InstitutionSharesValue% of portfolio
Engineers Gate Manager LP19,849$30.4K0.00%
Susquehanna International Group, LLP12,374$18.9K0.00%
Millennium Management LLC12,220$18.7K0.00%
HighTower Advisors, LLC10,000$15.0K0.00%

Sold out (10)

Institutions that held InflaRx N.V. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of IFRX in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Woodline Partners LP173,586$302.0K
Marshall Wace, LLP33,824$58.9K
Toroso Investments, LLC13,057$22.7K
Two Sigma Securities, LLC12,070$21.0K
Advisor Group Holdings, Inc.8,700$15.1K
Steward Partners Investment Advisory, LLC4,800$8.35K
Wetzel Investment Advisors, Inc.2,000$3.08K
Group One Trading, L.P.795$1.38K
Qube Research & Technologies Ltd770$1.34K
Simplex Trading, LLC449$0